Rapidly progressive Alzheimer';s disease and elevated 14-3-3 proteins in cerebrospinal fluid

Age and Ageing

Volumn 37, Issue 4, 2008, Pages 467-469

  Jayaratnam, Skanda ^a   Khoo, Angela Kim Ling ^a   Basic, David ^a  

^a LIVERPOOL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTINUCLEAR ANTIBODY; CARBAMAZEPINE; CREATININE; PROTEIN 14 3 3; UREA;

AGED; ALCOHOLISM; ALZHEIMER DISEASE; AUTOPSY; BRAIN DISEASE; CASE REPORT; COGNITIVE DEFECT; DEATH; DEHYDRATION; DEMENTIA; DISEASE COURSE; DISORIENTATION; DNA BINDING; ELECTROENCEPHALOGRAM; ERYTHROCYTE SEDIMENTATION RATE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; LETTER; MALE; MINI MENTAL STATE EXAMINATION; MYOCLONUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PNEUMONIA; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; REHYDRATION; TONIC CLONIC SEIZURE; URINARY TRACT INFECTION; VASCULITIS; VOMITING; WEIGHT REDUCTION;

14-3-3 PROTEINS; AGED; ALZHEIMER DISEASE; DISEASE PROGRESSION; EPILEPSIES, MYOCLONIC; FATAL OUTCOME; HUMANS; MALE; SEVERITY OF ILLNESS INDEX;

EID: 47049089362     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afn094     Document Type: Letter

References (11)

1. Steinhoff BJ, Zerr I, Glatting M et al. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol 2004; 56: 702-8.
2. Tan EM, Feltkamp TE, Smolen JS et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 1997; 40: 1601-11.
3. Braak H, Braak E. Neuropathological staging of Alzheimerrelated changes. Acta Neuropathol 1991; 82: 239-59.
4. Huang N, Marie SK, Livramento JA et al. 14-3-3 protein in the CSF of patients with rapidly progressive dementia. Neurology 2003; 61: 354-7
5. Fu H, Subramanian RR, Masters SC. 14-3-3 proteins: Structure, function, and regulation. Annu Rev Pharmacol Toxicol 2000; 40: 617-647.
6. Zerr I, Pocchiari M, Collins S et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000; 55: 811-5.
7. Zerr I, Poser S. Clinical diagnosis and differential diagnosis of CJD and vCJD. With special emphasis on laboratory tests. APMIS 2002; 110: 88-98.
8. Burkhard PR, Sanchez JC, Landis T et al. CSF detection of the 14-3-3 protein in unselected patients with dementia. Neurology 2001; 56: 1528-33.
9. Castellani RJ, Colucci M, Xie Z et al. Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Neurology 2004; 63: 436-42.
10. Reinwald S, Westner IM, Niedermaier N. Rapidly progressive Alzheimer's disease mimicking Creutzfeldt-Jakob disease. J Neurol 2004; 251: 1020-2.
11. Golde TE. Disease modifying therapy for AD. J Neurochem 2006; 99: 689-707.